MetLife Investment Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-32,094
| Closed | -$1.64M | – | 2840 |
|
2024
Q4 | $1.64M | Buy |
32,094
+1,191
| +4% | +$60.8K | 0.01% | 1155 |
|
2024
Q3 | $1.27M | Hold |
30,903
| – | – | 0.01% | 1255 |
|
2024
Q2 | $1.49M | Sell |
30,903
-16,956
| -35% | -$816K | 0.01% | 1132 |
|
2024
Q1 | $2.3M | Sell |
47,859
-8,124
| -15% | -$390K | 0.02% | 897 |
|
2023
Q4 | $3.63M | Sell |
55,983
-378
| -0.7% | -$24.5K | 0.03% | 664 |
|
2023
Q3 | $3.69M | Sell |
56,361
-779
| -1% | -$50.9K | 0.03% | 604 |
|
2023
Q2 | $3.32M | Buy |
57,140
+3,196
| +6% | +$186K | 0.02% | 698 |
|
2023
Q1 | $3.33M | Sell |
53,944
-584
| -1% | -$36.1K | 0.02% | 684 |
|
2022
Q4 | $3.47M | Sell |
54,528
-1,301
| -2% | -$82.7K | 0.03% | 649 |
|
2022
Q3 | $4.06M | Buy |
55,829
+9,357
| +20% | +$680K | 0.03% | 517 |
|
2022
Q2 | $3.16M | Buy |
46,472
+27,651
| +147% | +$1.88M | 0.02% | 690 |
|
2022
Q1 | $1.71M | Buy |
18,821
+6,604
| +54% | +$599K | 0.01% | 1063 |
|
2021
Q4 | $1.12M | Hold |
12,217
| – | – | 0.01% | 1082 |
|
2021
Q3 | $991K | Hold |
12,217
| – | – | 0.01% | 1119 |
|
2021
Q2 | $1.14M | Sell |
12,217
-9,674
| -44% | -$902K | 0.01% | 1095 |
|
2021
Q1 | $2.34M | Buy |
21,891
+18,483
| +542% | +$1.98M | 0.02% | 808 |
|
2020
Q4 | $297K | Hold |
3,408
| – | – | ﹤0.01% | 1774 |
|
2020
Q3 | $235K | Buy |
+3,408
| New | +$235K | ﹤0.01% | 1765 |
|